Testing
 
Project Tracking System
username    password    Login

 

 

Press Releases
  
 

 
12/23/2008
WuXi AppTec Selects H-Cube® from ThalesNano for Laboratory-based Hydrogenation
December 23, 2008 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today its selection of H-Cube® from ThalesNano Inc. for laboratory-based hydrogenation. WuXi thus joins all the top 20 pharmaceutical companies worldwide that have introduced and adopted the H-Cube technology.
12/18/2008 WuXi PharmaTech Shanghai Rodent Facility Awarded AAALAC Accreditation
12/18/2008 WuXi PharmaTech (NYSE: WX) Holds Its Second Life Science and Chemistry Awards Ceremony in Beijing
11/13/2008 WuXi PharmaTech Appoints Ying Han to Its Board of Directors
11/10/2008 WuXi PharmaTech Awarded in Deloitte Technology Fast 50 China 2008 List for the Fourth Consecutive Year
11/7/2008 WuXi PharmaTech Signs New Collaboration Agreement with Pfizer
10/16/2008 WuXi PharmaTech Expands Collaboration for Fully Integrated Services
9/29/2008 WuXi PharmaTech (NYSE: WX) Maintains Original Strategy to Provide Toxicology Services in China
9/23/2008 WuXi AppTec Life Science and Chemistry Award 2008 Launched Warmly
8/22/2008 WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
Total 34   First Prev Next Last Page：1/4Page  10/Page

 
 
Copyright © 2008 WuXi AppTec Co., Ltd. All rights reserved.